Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 21 , ISSUE 9 ( 2017 ) > List of Articles


Elevated red cell distribution width as a prognostic marker in severe sepsis: A prospective observational study

Subhash Varma, Neelam Varma, Aditya Jandial, Susheel Kumar

Keywords : 30-day mortality, Acute Physiology and Chronic Health Evaluation II score, red cell distribution width, severe sepsis

Citation Information : Varma S, Varma N, Jandial A, Kumar S. Elevated red cell distribution width as a prognostic marker in severe sepsis: A prospective observational study. Indian J Crit Care Med 2017; 21 (9):552-562.

DOI: 10.4103/ijccm.IJCCM_208_17

License: CC BY-ND 3.0

Published Online: 01-09-2018

Copyright Statement:  Copyright © 2017; The Author(s).


Introduction: Sepsis is a dysregulated host response to infection resulting in potentially life-threatening organ dysfunction. Elevation in red cell distribution width (RDW), a simple routinely done investigation, could be a prognostic marker in these patients. Methods: Between January 2014 and June 2015, 200 patients with severe sepsis at admission were prospectively evaluated for association between RDW at admission and 30-day mortality. Besides the groups of raised and normal RDW, study population was further analyzed after categorizing into three RDW groups as follows: ≤14.5%, 14.6–17.3%, and >17.3% as well. To find out factors associated independently with 30-day mortality, we applied multivariate logistic regression analysis. Results: Among 200 patients, 115 (57.5%) were males. Mean age of the study subjects was 51.32 ± 16.98 years. Mean RDW at admission was 17.40 ± 3.21%, ranging from 12.6% to 33.3%. Mean Acute Physiology and Chronic Health Evaluation II (APACHE II) score of study population at admission was 22.49 ± 5.72. One hundred and fourteen (57%) patients had 30-day mortality. Even though RDW showed a hierarchical association with 30-day mortality among three RDW groups, it was not found to be an independent predictor of 30-day mortality. APACHE II score, serum albumin, partial pressure of arterial oxygen/fraction of inspired oxygen ratio, and serum fibrinogen level at admission were observed to be independent predictors of 30-day mortality. Conclusions: In severe sepsis patients, RDW though showed a graded relationship with 30-day mortality was not found to be an independent predictor of 30-day mortality.

PDF Share
  1. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014;5:4-11.
  2. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-51.
  3. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-3.
  4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
  5. Afessa B, Keegan MT, Mohammad Z, Finkielman JD, Peters SG. Identifying potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 2004;126:1905-9.
  6. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
  7. Marshall JC, Reinhart K, International Sepsis Forum. Biomarkers of sepsis. Crit Care Med 2009;37:2290-8.
  8. Hou H, Sun T, Li C, Li Y, Guo Z, Wang W, et al. An overall and dose-response meta-analysis of red blood cell distribution width and CVD outcomes. Sci Rep 2017;7:43420.
  9. Zorlu A, Bektasoglu G, Guven FM, Dogan OT, Gucuk E, Ege MR, et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol 2012;109:128-34.
  10. Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS, et al. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care 2011;15:R194.
  11. Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Red cell distribution width and all-cause mortality in critically ill patients. Crit Care Med 2011;39:1913-21.
  12. Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005;20:83-90.
  13. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009;133:628-32.
  14. Jo YH, Kim K, Lee JH, Kang C, Kim T, Park HM, et al. Red cell distribution width is a prognostic factor in severe sepsis and septic shock. Am J Emerg Med 2013;31:545-8.
  15. Wang F, Pan W, Pan S, Ge J, Wang S, Chen M, et al. Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med 2011;43:40-6.
  16. Kim CH, Park JT, Kim EJ, Han JH, Han JS, Choi JY, et al. An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care 2013;17:R282.
  17. World Health Organization. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System Geneva: WHO; 2011. Available from: [Last accessed on 2017 May 02].
  18. Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 2015;52:86-105.
  19. Scharte M, Fink MP. Red blood cell physiology in critical illness. Crit Care Med 2003;31:S651-7.
  20. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
  21. Kolls JK. Oxidative stress in sepsis: A redox redux. J Clin Invest 2006;116:860-3.
  22. Lorente L, Martín MM, Abreu-Gonzólez P, Solé-Violón J, Ferreres J, Labarta L, et al. Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PLoS One 2014;9:e105436.
  23. van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017;17:407-20.
  24. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260-8.
  25. Afessa B, Gajic O, Keegan MT. Severity of illness and organ failure assessment in adult intensive care units. Crit Care Clin 2007;23:639-58.
  26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
  27. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P, et al. Human serum albumin: From bench to bedside. Mol Aspects Med 2012;33:209-90.
  28. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003;237:319-34.
  29. Hotchkiss RS, Sherwood ER. Immunology. Getting sepsis therapy right. Science 2015;347:1201-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.